Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Sep 2021. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2190191000001116 | Autologous CD34+ cells transduced to express human adenosine deaminase 1million-10million cells/ml dispersion for infusion bags 1 bag | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2190201000001119 | Autologous CD34+ cells transduced to express human adenosine deaminase 1million-10million cells/ml dispersion for infusion bags 1 bag (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Autologous CD34+ cells transduced to express human adenosine deaminase 1million-10million cells/ml dispersion for infusion bags 1 bag | Has dispensed dose form | Conventional release dispersion for infusion | true | Inferred relationship | Existential restriction modifier | ||
| Autologous CD34+ cells transduced to express human adenosine deaminase 1million-10million cells/ml dispersion for infusion bags 1 bag | Is a | Virtual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Autologous CD34+ cells transduced to express human adenosine deaminase 1million-10million cells/ml dispersion for infusion bags 1 bag | Has VMP | Autologous CD34+ cells transduced to express human adenosine deaminase 1million-10million cells/ml dispersion for infusion bags | true | Inferred relationship | Existential restriction modifier | ||
| Autologous CD34+ cells transduced to express human adenosine deaminase 1million-10million cells/ml dispersion for infusion bags 1 bag | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Autologous CD34+ cells transduced to express human adenosine deaminase 1million-10million cells/ml dispersion for infusion bags 1 bag | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Autologous CD34+ cells transduced to express human adenosine deaminase 1million-10million cells/ml dispersion for infusion bags 1 bag | Has dispensed dose form | Dispersion for infusion | false | Inferred relationship | Existential restriction modifier | ||
| Autologous CD34+ cells transduced to express human adenosine deaminase 1million-10million cells/ml dispersion for infusion bags 1 bag | Has specific active ingredient | Autologous CD34+ cells transduced to express human adenosine deaminase | true | Inferred relationship | Existential restriction modifier | ||
| Autologous CD34+ cells transduced to express human adenosine deaminase 1million-10million cells/ml dispersion for infusion bags 1 bag | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Strimvelis 1million-10million cells/ml dispersion for infusion bags (Orchard Therapeutics (Europe) Ltd) 1 bag | Is a | True | Autologous CD34+ cells transduced to express human adenosine deaminase 1million-10million cells/ml dispersion for infusion bags 1 bag | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR